(0.11%) 5 254.35 points
(0.12%) 39 807 points
(-0.12%) 16 379 points
(2.18%) $83.12
(1.92%) $1.751
(1.78%) $2 252.10
(1.40%) $25.10
(1.45%) $922.85
(0.36%) $0.927
(0.77%) $10.85
(0.13%) $0.792
(0.13%) $92.56
1 794.74% £ 18.00
Live Chart Being Loaded With Signals
Midatech Pharma plc, a drug delivery technology company, focuses on the research and development of medicines in the United Kingdom, rest of Europe, and internationally...
Stats | |
---|---|
Today's Volume | 1.38M |
Average Volume | 38 925.00 |
Market Cap | 31.20M |
EPS | £0 ( 2023-09-12 ) |
Last Dividend | £0 ( N/A ) |
Next Dividend | £0 ( N/A ) |
P/E | -0.220 |
ATR14 | £3.89 (91.46%) |
Volume Correlation
Midatech Pharma PLC Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Midatech Pharma PLC Correlation - Currency/Commodity
Midatech Pharma PLC Financials
Annual | 2022 |
Revenue: | £699 000 |
Gross Profit: | £-4.41M (-631.19 %) |
EPS: | £0 |
Q2 | 2018 |
Revenue: | £0.00 |
Gross Profit: | £0.00 (0.00 %) |
EPS: | £0 |
Q2 | 2017 |
Revenue: | £0.00 |
Gross Profit: | £0.00 (0.00 %) |
EPS: | £0 |
Q2 | 2016 |
Revenue: | £0.00 |
Gross Profit: | £0.00 (0.00 %) |
EPS: | £0 |
Financial Reports:
No articles found.
Midatech Pharma PLC
Midatech Pharma plc, a drug delivery technology company, focuses on the research and development of medicines in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; MTD211, a long-acting formulation of brexpiprazole for the treatment of schizophrenia and adjunctive treatment of major depressive disorder; and MTD219, a long-acting formulation of tacrolimus used to lower the risk of organ transplant rejection. It also offers drug delivery platforms, such as Q-Sphera, a polymer microsphere microtechnology used for sustained release drug delivery; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators